Postponement and Re-scheduling of Annual General Meeting
Biodexa Pharmaceuticals has adjourned its Annual General Meeting scheduled for today due to a lack of a quorum. The meeting has been rescheduled for June 30, 2026, at the Company's offices in Cardiff, with proxies submitted for the original meeting remaining valid.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.